Dana-Farber Cancer Institute (DFCI) United States of America (USA)
Date range: 1 May 2021 - 30 April 2022
Parent institution:Harvard University
Subject/journal group: All
The table to the right includes counts of all research outputs for Dana-Farber Cancer Institute (DFCI) published between 1 May 2021 - 30 April 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
|Earth & Environmental Sciences||2||0.02|
Share output for the past 5 years
Affiliated joint institutions and consortia
- ASAN Center for Cancer Genome Discovery (ASAN-CCGD)
- CLL Research Consortium (CRC)
- Center for Cancer Systems Biology (CCSB)
- Center for Molecular Imaging Research (CMIR)
- Children's Oncology Group (COG)
- Clinical Sequencing Exploratory Research (CSER)
- Collaboration for AIDS Vaccine Discovery (CAVD)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC)
- Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE)
- Hansjorg Wyss Institute for Biologically Inspired Engineering
- Harvard Stem Cell Institute (HSCI)
- ICGC Breast Cancer Project: Triple Negative/Lobular/Other
- ImmGen Consortium
- Joint Center for Cancer Precision Medicine
- Massachusetts Consortium on Pathogen Readiness (MASSCPR)
- Multiple Myeloma Research Consortium (MMRC)
- Parker Institute for Cancer Immunotherapy
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.